EUVIMEDEUVIMED entdecken
Open Access

Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6‐Year Prospective Registry Analysis

Brady J Anderson iD, Amy C Moreno iD, Yun Qing, J Jack Lee, Faye M Johnson iD, Miriam N Lango iD, Carly E A Barbon iD, Lavanya Tripuraneni, Ariana Sahli, Vicki Piper, Neil Gross iD, Clifton D Fuller iD und 3 weitere

Otolaryngology–Head and Neck Surgery · 2024

DOI: 10.1002/ohn.672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2024. Verfasst von Brady J Anderson und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Enteral Nutrition, Intubation, Gastrointestinal, Registries. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Patients treated for oropharyngeal cancer (OPC) have historically demonstrated high feeding tube rates for decreased oral intake and malnutrition. We re‐examined feeding tube practices in these patients. Study Design Retrospective analysis of prospective cohort from 2015 to 2021.

Setting

Single‐institution NCI‐Designated Comprehensive Cancer Center.

Methods

With IRB approval, patients with new oropharyngeal squamous cell cancer or (unknown primary with neck metastasis) were enrolled. Baseline swallowing was assessed via videofluoroscopy and Performance Status Scale for Head and Neck Cancer (PSSHN). G‐tubes or nasogastric tubes (NGT) were placed for weight loss before, during, or after treatment. Prophylactic NGT were placed during transoral robotic surgery (TORS). Tube duration was censored at last disease‐free follow‐up. Multivariate regression was performed for G‐tube placement (odds ratio [OR] [95% confidence interval [CI]) and removal (Cox hazard ratio, hazard ratio [HR] [95% CI]).

Results

Of 924 patients, most had stage I to II (81%), p16+ (89%), node‐positive (88%) disease. Median follow‐up was 2.6 years (interquartile range 1.5‐3.9). Most (91%) received radiation/chemoradiation, and 16% received TORS. G‐tube rate was 27% (5% after TORS). G‐tube risk was increased with chemoradiation (OR 2.78 [1.87‐4.22]) and decreased with TORS (OR 0.31 [0.15‐0.57]) and PSSHN‐Diet score ≥60 (OR 0.26 [0.15‐0.45]). G‐tube removal probability over time was lower for T3 to T4 tumors (HR 0.52 [0.38‐0.71]) and higher for PSSHN‐Diet score ≥60 (HR 1.65 [1.03‐2.66]).

Conclusions

In this modern cohort of patients treated for OPC, 27% received G‐tubes—50% less than institutional rates 10 years ago. Patients with preserved baseline swallowing and/or those eligible for TORS may have lower G‐tube risk and duration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oropharyngeal NeoplasmsEnteral NutritionIntubation, GastrointestinalRegistriesHumansMaleFemaleMiddle AgedRetrospective StudiesAgedProspective StudiesRobotic Surgical Procedures

Stichwörter der Autor:innen

G‐tubechemoradiationfeeding tubegastrostomynasogastricoropharyngeal cancer (OPC)radiationtransoral robotic surgery (TORS)

Autor:innen und Institutionen

  • Department of Otolaryngology, University of Iowa, Iowa City, Iowa, USA.
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Thoracic-Head & Neck, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Section of Speech Pathology & Audiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Brady J Anderson, Amy C Moreno, Faye M Johnson, Miriam N Lango, Carly E A Barbon, Neil Gross, Clifton D Fuller, Stephen Y Lai, Katherine A Hutcheson

Förderung

  • NIDCR NIH HHS
  • NCI NIH HHS

Zitieren

APA

Anderson, B. J., Moreno, A. C., Qing, Y., Lee, J. J., Johnson, F. M., Lango, M. N., Barbon, C. E. A., Tripuraneni, L., Sahli, A., Piper, V., Gross, N., Fuller, C. D., Lai, S. Y., Myers, J. N., & Hutcheson, K. A. (2024). Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6‐Year Prospective Registry Analysis. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.672

Vancouver

Anderson BJ, Moreno AC, Qing Y, Lee JJ, Johnson FM, Lango MN, et al. Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6‐Year Prospective Registry Analysis. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.672

BibTeX
@article{Anderson2024,
  author = {Anderson, Brady J and Moreno, Amy C and Qing, Yun and Lee, J Jack and Johnson, Faye M and Lango, Miriam N and Barbon, Carly E A and Tripuraneni, Lavanya and Sahli, Ariana and Piper, Vicki and Gross, Neil and Fuller, Clifton D and Lai, Stephen Y and Myers, Jeffrey N and Hutcheson, Katherine A},
  title = {Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6‐Year Prospective Registry Analysis},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2024},
  doi = {10.1002/ohn.672}
}
Kostenlos starten →